Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

13.74

0.00 (0.04%)

Jun 18, 2025, 4:00 PM - Market closed

Mineralys Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 18, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	895	613	354	-	-	-
Market Cap Growth	60.46%	73.31%	-	-	-	-
Enterprise Value	552	349	100	-	-	-
Last Close Price	13.73	12.31	8.60	-	-	-
PB Ratio	2.61	3.20	1.47	-	-	-
P/TBV Ratio	2.62	3.20	1.47	-	-	-
Debt / Equity Ratio	-	-	-	-	-	-1.25
Quick Ratio	25.63	13.53	22.57	13.65	2.10	0.28
Current Ratio	26.48	14.02	23.77	13.98	2.20	0.29
Return on Equity (ROE)	-56.31%	-82.24%	-41.38%	-53.00%	-1568.96%	-
Return on Assets (ROA)	-35.87%	-52.56%	-28.91%	-31.34%	-185.60%	-
Return on Capital (ROIC)	-37.61%	-55.62%	-30.45%	-34.99%	-335.62%	-
Earnings Yield	-21.07%	-29.02%	-20.34%	-	-	-
FCF Yield	-21.53%	-27.16%	-22.96%	-	-	-
Buyback Yield / Dilution	-22.76%	-34.13%	-600.33%	-3.67%	-7.64%	-

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q